Abstract
Treatment of dyskinetic disorders, in general, and of tardive dyskinesia (TD), in particular, is difficult. The opiate peptide enkephalin coexits with gamma aminobutyric acid in the projection neurons of striatum forming the "indirect" pathway. Several lines of preclinical evidence implicate this enkephalin-comediated pathway in the pathophysiology and therapeutics of dyskinesia. However, previous studies, most using relatively low doses of opioid antagonists, showed mixed results. The goal of the current study was to test whether moderately high doses of naltrexone, alone or in combination with a subtherapeutic dose of a gamma aminobutyric acid agonist, improve TD. In 2 double-blind, placebo-controlled, randomized, crossover trials, effects of naltrexone alone (n = 9) and in combination with clonazepam (n = 14) were tested on TD. In both trials, patients' antipsychotic medication and dose remained unchanged through the trial. Naltrexone dose was increased over a period of 3 weeks to 200 mg/d and maintained at that dose for another week. In the second study, patients were first stabilized on low dose (0.25 to 0.5 mg) of clonazepam for 4 weeks or longer. In addition to the TD scores, saccadic peak velocity and latency, as measur...Continue Reading
References
Oct 1, 1992·Clinical Pharmacology and Therapeutics·A L van SteveninckA F Cohen
May 1, 1992·Annals of Neurology·G Erenberg, R J Lederman
Jul 1, 1991·Annals of Neurology·R KurlanP G Como
Jul 1, 1990·Trends in Neurosciences·M R DeLong
Jul 3, 1989·Brain Research·R L AlbinS Gilman
Jan 1, 1987·Psychopharmacology·I BlumE Roberts
Jul 1, 1986·Neuropeptides·J L Cadet, T L Braun
Jul 4, 1985·Neuroscience Letters·R J RodgersB Kelway
Dec 1, 1985·Biological Psychiatry·R Sandyk, S R Snider
Apr 1, 1982·Archives of General Psychiatry·G F JohnsonJ M Rey
Apr 1, 1982·Archives of General Psychiatry·N R Schooler, J M Kane
Jan 1, 1982·Annals of the New York Academy of Sciences·J VolavkaG Koz
Nov 1, 1994·Synapse·M F EganJ E Kleinman
Oct 1, 1993·Movement Disorders : Official Journal of the Movement Disorder Society·A J StoesslH Frydryszak
Jul 1, 1994·Movement Disorders : Official Journal of the Movement Disorder Society·O RascolA Rascol
Jul 1, 1993·British Journal of Clinical Pharmacology·A RichensR W Marshall
Apr 18, 1997·Psychiatry Research·S L CassadyC A Tamminga
Dec 1, 1996·General Pharmacology·K S RózsaG B Stefano
May 20, 1998·Journal of Clinical Pharmacology·P D KrobothJ A Sweeney
Mar 4, 2000·Behavioural Brain Research·G S MassonO Blin
Oct 24, 2000·Schizophrenia Research·G K ThakerJ Sherr
Mar 20, 2001·Journal of Neurology, Neurosurgery, and Psychiatry·A J MansonA J Lees
Apr 4, 2001·The International Journal of Neuropsychopharmacology·Robin A. EmsleyDan J. Stein
Dec 26, 2001·Neuropharmacology·G C D EichenbergerN C Coimbra
Jun 29, 2002·Neuroscience·S E McCormick, A J Stoessl
Nov 2, 2002·The British Journal of Psychiatry : the Journal of Mental Science·Jennifer HallidayRobin McCreadie
Citations
Mar 17, 2006·Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology·Igor ElmanScott E Lukas
Jul 15, 2006·Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology·Pierluigi Onali, Maria C Olianas
Dec 1, 2006·Schizophrenia Bulletin·Bruce I TuretskyNeal R Swerdlow
Feb 16, 2005·Expert Opinion on Drug Safety·Robert L Rodnitzky
Apr 9, 2013·Frontiers in Neuroendocrinology·Flavia di MichelePatrizia Longone
Dec 26, 2012·Neuroscience·A Laux-BiehlmannY Goumon
Nov 25, 2004·Brain Research Bulletin·Nilza P AraujoRoberto Frussa-Filho
Jul 26, 2005·Peptides·Richard J Bodnar, Gad E Klein
Jan 21, 2018·The Cochrane Database of Systematic Reviews·Hanna BergmanKarla Soares-Weiser
Jun 10, 2020·Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology·Samuel D ClarkAnissa Abi-Dargham
Jun 14, 2003·The Cochrane Database of Systematic Reviews·K V Soares-Weiser, C Joy
Mar 20, 2018·The Cochrane Database of Systematic Reviews·Karla Soares-WeiserHanna Bergman
Jul 21, 2006·The Cochrane Database of Systematic Reviews·P S Bhoopathi, K Soares-Weiser
May 5, 2000·The Cochrane Database of Systematic Reviews·J J McGrath, K V Soares